Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Dyrlægehuset Aulum ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   12.1% 14.5% 11.7% 12.2% 11.0% 9.4% 19.2% 19.2%   Credit score (0-100)   21 15 19 18 21 26 7 7   Credit rating   BB BB BB BB BB BB B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   897 1,298 1,821 2,092 2,068 2,444 0.0 0.0   EBITDA   403 323 367 437 418 293 0.0 0.0   EBIT   252 172 213 325 297 165 0.0 0.0   Pre-tax profit (PTP)   161.0 92.0 162.0 300.0 286.0 147.1 0.0 0.0   Net earnings   125.0 72.0 126.0 227.0 222.0 114.7 0.0 0.0   Pre-tax profit without non-rec. items   161 92.0 162 300 286 147 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Tangible assets total   713 568 465 368 270 175 0.0 0.0   Shareholders equity total   -178 -106 20.0 247 319 284 234 234   Interest-bearing liabilities   600 396 278 3.0 5.0 7.1 0.0 0.0   Balance sheet total (assets)   1,022 1,034 1,423 1,026 1,139 1,072 234 234   Net Debt   588 281 134 -163 -381 -505 -234 -234     See the entire balance sheet 1000.0 Volume  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   897 1,298 1,821 2,092 2,068 2,444 0.0 0.0   Gross profit growth   21.1% 44.7% 40.3% 14.9% -1.1% 18.2% -100.0% 0.0%   Employees   2 3 4 4 4 5 0 0   Employee growth %   0.0% 50.0% 33.3% 0.0% 0.0% 25.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,022 1,034 1,423 1,026 1,139 1,072 234 234   Balance sheet change%   -10.2% 1.2% 37.6% -27.9% 11.0% -5.9% -78.2% 0.0%   Added value   403.0 323.0 367.0 437.0 409.0 293.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -278 -296 -257 -209 -219 -223 -175 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   28.1% 13.3% 11.7% 15.5% 14.4% 6.8% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   19.1% 14.7% 16.8% 26.7% 27.8% 15.1% 0.0% 0.0%   ROI %   25.4% 25.7% 54.0% 106.2% 85.3% 46.3% 0.0% 0.0%   ROE %   11.6% 7.0% 23.9% 170.0% 78.4% 38.0% 0.0% 0.0%   1000.0 Solidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Equity ratio %   -14.8% -9.3% 1.4% 24.1% 28.0% 26.5% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   145.9% 87.0% 36.5% -37.3% -91.1% -172.3% 0.0% 0.0%   Gearing %   -337.1% -373.6% 1,390.0% 1.2% 1.6% 2.5% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   13.2% 16.1% 15.7% 19.2% 375.0% 321.5% 0.0% 0.0%   1000.0 Liquidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Quick Ratio   0.2 0.3 0.6 0.6 0.8 0.9 0.0 0.0   Current Ratio   0.3 0.5 0.7 0.9 1.1 1.2 0.0 0.0   Cash and cash equivalent   12.0 115.0 144.0 166.0 386.0 512.1 0.0 0.0   1000.0 Capital use efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -558.0 -506.0 -413.0 -71.0 95.0 131.6 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   202 108 92 109 102 59 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   202 108 92 109 105 59 0 0   EBIT / employee   126 57 53 81 74 33 0 0   Net earnings / employee   63 24 32 57 56 23 0 0